RT Journal Article SR Electronic T1 Validating quantitative PCR assays for cell-free DNA detection without DNA extraction: Exercise induced kinetics in systemic lupus erythematosus patients JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.01.17.21249972 DO 10.1101/2021.01.17.21249972 A1 Elmo W.I. Neuberger A1 Alexandra Brahmer A1 Tobias Ehlert A1 Katrin Kluge A1 Keito F.A. Philippi A1 Simone C. Boedecker A1 Julia Weinmann-Menke A1 Perikles Simon YR 2021 UL http://medrxiv.org/content/early/2021/01/20/2021.01.17.21249972.abstract AB Circulating cell-free DNA (cfDNA) has been investigated as a screening tool for many diseases. To avoid expensive and time-consuming DNA isolation, direct quantification PCR assays can be established. However, rigorous validation is required to provide reliable data in the clinical and non-clinical context. Considering International Organization for Standardization, as well as bioanalytical method validation guidelines we provide a comprehensive procedure to validate assays for cfDNA quantification from unpurified blood plasma. A 90 and 222 bp assay was validated to study the kinetics of cfDNA after exercise in patients with systemic lupus erythematosus. The assays showed ultra-low limit of quantification (LOQ) with 0.47 and 0.69 ng/ml, repeatability ≤ 11.6% (95% CI: 8.1–20.3), and intermediate precision ≤ 12.1% (95% CI: 9.2-17.7). Incurred sample reanalysis confirmed the precision of the procedure. The additional consideration of pre-analytical factors shows that centrifugation speed and temperature do not change cfDNA concentrations. In SLE patients cfDNA increases ∼2 fold after all out walking exercise, normalizing after 60 min of rest. The established assays allow reliable and cost-efficient quantification of cfDNA in minute amounts of plasma in the clinical setting and can be used as a standard to control pre-analytical factors including cfDNA losses during purification.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03942718Funding StatementThe study was funded by the internal research funding of the Johannes Gutenberg-University of Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The experimental procedures were approved by the Human Ethics Committee of Rhineland-Palatine and were in line with the Declaration of Helsinki of the World Medical Association. All participants gave their informed consent for study participation.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available from the corresponding author on reasonable request.